Publications by authors named "Michael Duerr"

Claim this Profile
I
Impact of Hepatitis B Infection on Patient and Graft Survival After Kidney Transplantation.
Anissa Paschereit, Vivien Greese, Kayo Sakurayama, Michael Duerr, Fabian Halleck

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders.
Besarte Vrellaku, Ilda Sethw Hassan, Rebecca Howitt, Christopher P Webster, Eli Harriss, Michael Duerr

Mol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary CD8+HLA-DR+ T Cell Abundance Non-invasively Predicts Kidney Transplant Rejection.
Emil Grothgar, Nina Goerlich, Bjoern Samans, Christopher M Skopnik, Diana Metzke, Michael Duerr

Front Med (Lausanne)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant Recipients.
Friederike Bachmann, Klemens Budde, Norbert Suttorp, Tilman Lingscheid, Miriam Songa Stegemann, Michael Duerr

Transpl Int· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Features and Risk Factors of Proteinuria in Transplant Glomerulopathy.
Qiang Zhang, Klemens Budde, Danilo Schmidt, Fabian Halleck, Michael Duerr

Front Med (Lausanne)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal Segmental Glomerulosclerosis and Recurrence in Living Donor Recipients.
Josef Mang, Linda Hennig, Lutz Liefeldt, Michael Duerr, Lukas J Lehner

Res Rep Urol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Complexity of Death-Censored Kidney Allograft Failure.
Manuel Mayrdorfer, Lutz Liefeldt, Kaiyin Wu, Birgit Rudolph, Qiang Zhang, Michael Duerr

J Am Soc Nephrol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection.
Konstantin Doberer, Michael Duerr, Philip F Halloran, Farsad Eskandary, Klemens Budde

J Am Soc Nephrol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between proteinuria and allograft survival in patients with transplant glomerulopathy: a retrospective single-center cohort study.
Qiang Zhang, Birgit Rudolph, Mira Choi, Friederike Bachmann, Danilo Schmidt, Michael Duerr

Transpl Int· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients.
Anja Staeck, Dmytro Khadzhynov, Anna Kleinsteuber, Lukas Lehner, Michael Duerr

Transpl Immunol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients.
Michael Duerr, Lutz Liefeldt, Frank Friedersdorff, Mira Choi, Robert Öllinger

J Clin Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Seroprevalence of SARS-CoV-2 Antibodies during Systematic Antibody Screening and Serum Responses in Patients after COVID-19 in a German Transplant Center.
Mira Choi, Friederike Bachmann, Marcel Ganesh Naik, Wiebke Duettmann, Michael Duerr

J Clin Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Risk Factors and Long-Term Outcomes in Kidney Transplant Patients with Identified Lymphoceles.
Lukas J Lehner, Arnim Hohberger, Lisanne Marschke, Nils Lachmann, Robert Peters, Michael Duerr

J Clin Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept.
Mira Choi, Friederike Bachmann, Kaiyin Wu, Nils Lachmann, Danilo Schmidt, Michael Duerr

BMC Nephrol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of graft survival at diagnosis of antibody-mediated renal allograft rejection: a retrospective single-center cohort study.
Johannes Waiser, Jens Klotsche, Nils Lachmann, Kaiyin Wu, Birgit Rudolph, Michael Duerr

Transpl Int· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Living Kidney Donor Profile Index in a European cohort and comparison of long-term outcomes with US results.
Gregor Rehse, Fabian Halleck, Dmytro Khadzhynov, Lukas J Lehner, Anna Kleinsteuber, Michael Duerr

Nephrol Dial Transplant· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus-Positive Kidney Transplant Recipients.
Eva Schrezenmeier, Friederike Hoffmann, Carsten Jaeger, Jens Schrezenmeier, Jan Lisec, Michael Duerr

Ther Drug Monit· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients.
Michael Duerr, Eva V Schrezenmeier, Lukas J Lehner, Léon Bergfeld, Petra Glander

BMC Nephrol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy.
Claudia Sommerer, Michael Duerr, Oliver Witzke, Frank Lehner, Wolfgang Arns

Am J Transplant· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.
Claudia Sommerer, Oliver Witzke, Frank Lehner, Wolfgang Arns, Petra Reinke, Michael Duerr

BMC Nephrol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Kidney Donor Profile Index in a European cohort.
Lukas Johannes Lehner, Anna Kleinsteuber, Fabian Halleck, Dmytro Khadzhynov, Eva Schrezenmeier, Michael Duerr

Nephrol Dial Transplant· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Acute Antibody-Mediated Renal Allograft Rejection With Cyclophosphamide.
Johannes Waiser, Michael Duerr, Klemens Budde, Birgit Rudolph, Kaiyin Wu

Transplantation· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplanting HCV-Infected Kidneys into Uninfected Recipients.
Fabian Halleck, Klemens Budde, Michael Duerr, Oliver Staeck, Joerg Hofmann

N Engl J Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.
Klemens Budde, Martin Zeier, Oliver Witzke, Wolfgang Arns, Frank Lehner, Michael Duerr

Nephrol Dial Transplant· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by Step.
Nils Lachmann, Michael Duerr, Constanze Schönemann, Axel Pruß, Klemens Budde

J Immunol Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis